Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.. AIDS Research and Human Retroviruses, 32(3): 279-83 (2016).

Publication Latest Publications

Title: Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
Authors: Rego FF, de Oliveira T, Giovanetti M, Galvao-Castro B, Goncalves MS, Alcantara LC..
Journal: AIDS Research and Human Retroviruses,32(3):279-83 (2016)

Journal Impact Factor (I.F.): 2.457
Number of citations (Google Scholar): 1

Abstract

The aim of this study was to analyze patients by deep sequencing the HTLV-1 LTR region in order to determine if minor and/or major mutations in this promoter region might be associated with TSP/HAM outcome or proviral load or HTLV-1 expression. This study is a cross-sectional analyze of 29 HTLV-1 infected patients with TSP/HAM or asymptomatic carriers. Proviral DNA from those subjects was submitted to a nested-PCR for the HTLV-1 LTR 5' region. The HTLV-1 LTR5' purified products were submitted to deep sequencing using the Ion Torrent? sequencing technology (Life Technologies, Carlsbad, CA).

We found that samples with low proviral load showed more detected minor than the samples with high proviral load. Mutations in 136 positions were found over the 520 bp analyzed fragment of HTLV-1 LTR 5' with at least 1% frequency. Eleven mutations were present in the previously determined major TFBS and in more than a patient, indicating that might be a differential HTLV-1 expression comparing individuals or in different cells from the same individual.

Three mutations were statistically significant using the Fisher non-parametric test between the groups but were not present in previously determined TFBS (G126C/T, G306C and C479T). Those mutations that were not present in previously determined TFBS were statistically significant in this study and most frequent in patients with low proviral load or in asymptomatic carriers. Despite those mutations being not present in previously determined TFBS, one of those mutations (G306C/A) was present in a Sp-1 binding site determined by in silico analyze, and its presence abrogated the site for Sp-1 binding and created a new possible ATF binding site.


Impact of point-of-care Xpert MTB/RIF on tuberculosis treatment initiation: a cluster randomised trial
Journal: Am J Respir Crit Care Med (2017)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
Journal: Pharmacogenomics and Personalized Medicine (2017)

Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa
Journal: Journal of Antimicrobial Chemotherapy (2017)
All publications...


KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), K-RITH Tower Building, Nelson R Mandela School of Medicine, UKZN

Contact: Prof. Tulio de Oliveira, Tel: +27 31 260 4898, Email: tuliodna@gmail.com & deoliveira@ukzn.ac.za

Page design updated 2013. Many of the pages were previously hosted at bioafrica.net.